The six signature genes were composed of IRF2, ZDHHC9, KCNJ11, LRP11, PCMT1, and TMEM70. IRF2, a transcription factor in the interferon gamma signal transduction pathway, was different expression in breast cancer and normal tissues. This evidence concerns the gene IRF2 and breast carcinoma.